Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > Global license or buyout of pipeline?
View:
Post by biorun on Dec 17, 2021 9:26am

Global license or buyout of pipeline?

From the release:

".....pharmaceutical company for the rights to TFC-1067"

Is the one whole pipeline up for sale? 


Whoa.
Comment by navajojoe on Dec 17, 2021 9:36am
This post has been removed in accordance with Community Policy
Comment by biorun on Dec 17, 2021 10:02am
What do you think? It could be for global license or outright sale. Both options are on the table, are they not? can we cut it out with the vulgarity and just have an honest conversation? 
Comment by navajojoe on Dec 17, 2021 10:17am
This post has been removed in accordance with Community Policy
Comment by biorun on Dec 17, 2021 11:51am
But the actual IP can also be sold and you can't discount that as well. So if you are insisting on ruling out that option, that in fact is dishonest all the same. So lets agree to disagree or we can do this all day if you want.
Comment by lscfa on Dec 17, 2021 10:22am
What about TFC-1394? These boneheads have created confusion just like when they licensed inferior ingredient TFC-849 to Valeant. Asia  We continue to implement our Asia strategy and are in discussions with a China-based company which has established cosmetic development excellence as discussed in our last news update. An evolving and varied regulatory landscape for new ...more  
Comment by Pareto8020 on Dec 17, 2021 10:57am
It is amazing how SBM over the years has made all these announcements about engaging consultants and plans for compounds to do with everything from plants to organ transplants and then they never mention them again and it fades away into the ether never to be spoken of again.  It's like they are blind men throwing darts at a board hoping they'll hit that elusive bullseye.  I ...more  
Comment by biorun on Dec 17, 2021 11:52am
And yes, this library was separated/created for a reason. Think people.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities